Root canal treatment for infections may significantly lower blood glucose levels, according to a study in the Journal of Translation Medicine that followed 65 patients for two years. Those who underwent root canals experienced notable improvements in blood glucose, cholesterol and fatty acid levels, as well as reduced inflammation.

Researchers have engineered human gastric organoids from embryonic stem cells to produce insulin, a potential breakthrough for type 1 diabetes treatment that could bypass immune rejection and donor scarcity, though more research is needed to ensure safety and efficacy. The findings were reported in Stem Cell Reports.

Obstructive sleep apnea is a common yet often underrecognized condition among older adults, with prevalence increasing due to age and obesity. In the US last year, 41% of women and 59% of men met the criteria for OSA. Research indicates that 90% of men and 78% of women are diagnosed with the condition between the ages of 60 and 85.

A study in BMJ Medicine associated eating disorders with long-term physical and mental health risks, including diabetes, depression, kidney or liver failure, broken bones and premature death. Researchers said that while the risk was highest within the first year of diagnosis, it remained elevated for years. The study included more than 24,700 people ages 10 to 44 who had an eating disorder diagnosis and 493,000 people who did not have the diagnosis.

At AMP 2025, bioethicist Takunda Matose, PhD, discussed the ethical considerations of using AI in health care. He emphasized the importance of mindful data usage, addressing inherent biases, and the need for human discretion in AI systems. Matose argued that while AI excels in data analysis, its limitations due to bias and ethical challenges must be acknowledged. He urged stakeholders to consider the broader implications of AI, focusing on patient and stakeholder needs, and to thoughtfully integrate AI into health care systems.

A study explores how patients use health care chatbots like the UCHealth portal's Livi, revealing that while these tools are popular for administrative tasks, they are also used for sensitive topics due to perceived anonymity. The research, published in the Journal of the American Medical Informatics Association, notes that older users were more comfortable sharing information than younger ones.

The introduction of biosimilars led to a reduction in insulin glargine prices across 28 European countries, according to a study in BMJ Open. Between 2013 and 2023, the median price of insulin glargine dropped 21.6% following the entry of biosimilars into the market.